An observational study in Pediatrics, Neurologic Dysfunction and Vibration Therapy, sponsored by Children's Mercy Hospital Kansas City. Recruiting at 1 site in United States. Open to participants aged 6 Months to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Children's Mercy Hospital Kansas City · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 185 studies in Neurologic Manifestations with a site in United States — 24 open to participants now, 38 under way, 6 of them phase 3. Neurologic Manifestations · United States.
Among the 185 studies in Neurologic Manifestations with a site in United States, this one is the 41st largest by planned enrollment of the 47 observational ones that give a count, is one of 9 that started in 2026, is one of 47 observational ones, reaches primary completion later than 12 of the 37 other live ones, and was the 181st registered.
427 studies on the registry are indexed under Neurologic Manifestations; 80 are open to participants now.
Browse Neurologic Manifestations studies →24 of the 185 studies in Neurologic Manifestations with a site in United States are open now. Recruiting first, the newest first:
Brian J.Gill · Sites in United States
Ages 22–65
Teleflex · Sites in United States, France, Latvia and 1 more country
Ages 18–80
Peter C. Gerszten, MD · Sites in United States
Ages 21–75 · Healthy volunteers
Indiana University · Sites in United States
Ages 18+
Alexander T. Yahanda · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 59 Neurologic Manifestations studies recruiting now, 31 (53%) set no upper age limit and 15 (25%) stop at 75 or younger; 15 take children under 18; 12 take healthy volunteers.
This study: 6 Months to 17 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
185 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 25 · Phase 2 35 · Phase 3 20 · Phase 4 3
First in 1988; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 141 across 131 observational studies indexed under Neurologic Manifestations.
Median enrollment 34 across the 136 interventional studies, 100 across the 47 observational. Of the 126 that completed or were terminated, 41 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
38 of 185 have an industry lead sponsor. The 10 most frequent:
Children's Mercy Hospital Kansas City is the lead sponsor of 210 studies on the registry; 20 are open to participants now.
Of its 18 completed or terminated interventional studies of FDA-regulated products, 14 (78%) have results posted.
Children's Mercy Hospital Kansas City has 1 study filed under Neurologic Manifestations — fewer than ten, so there is no comparison to draw.
17 of the studies in Neurologic Manifestations with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06891443Phase 3Laboratoires TheaStudy to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) | 2027-11 |
| NCT01988883Vanderbilt University Medical CenterModafinil and Cognitive Function in POTS | 2026-12 |
| NCT07223827Indiana UniversityHandheld Point of Care Electro-Diagnostic Device | 2026-12 |
| NCT07226011Medical University of South CarolinaAccelerated High-Dose tDCS for Depression | 2026-12-28 |
| NCT07218133Alexander T. YahandaTrans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery | 2027-01 |
Add all 17 to your calendar (.ics) → With an account.
Among the 185 studies in Neurologic Manifestations with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a single site, mixed methods, feasibility study of the ViBandz device at a Midwest pediatric tertiary care hospital in a physical and occupational therapy clinic.
This proposal is for a single-site, feasibility study of the use of ViBandz in a treatment population. The analysis is a mixed methods approach with quantitative feedback on surveys and a secondary qualitative review of audio/+/- video that was obtained during the device use. The survey will be done immediately after the study on a device in clinic by the parents. If parents do not have time to finish it then, an email will be sent. Video and audio during the visit will provide additional rich data to understand the device beyond what a standard quantitative survey could provide. Subjects will have their standard clinical care- targeted vibration and then after their visit is completed, they will complete the use of the ViBandz This order will occur with all participants.
Minimum of 15 children and their parent/LAR (dyad) who have a neurologic condition resulting in abnormal movement of at least one extremity to be enrolled at Children's Mercy Hospital.
Inclusion Criteria (Children):
Exclusion Criteria (Children):
Inclusion Criteria (Parent/LAR):
Exclusion Criteria (Parent/LAR):
ViBandz is a device with straps and small vibrating motors that can be worn over muscles for stimulation and targeted vibration therapy. It was created to address the need for a hands-free vibrating device. There are different motor sizes and strap sizes for best fit with the patient. ViBandz also features a base station for powering the device and a key fob used to control the vibration therapy. Once all appropriate signatures have been obtained and all family/subject questions have been addressed, the subject will undergo their scheduled standard clinical Care (SOC) visit. The time with the ViBandz (10-15 minutes) will be less than full traditional targeted therapy (45 minutes) will help to control for subject fatigue as the vibration feeling stimulates muscles.: Video recordings via an iPad or similar device may be obtained during the subject's visit. These videos will allow for a closer inspection of subject interaction with the ViBandz.
End User System Usability Feedback on ViBandz
Overall themes to be investigated will include ease of use, perceived comfort in using the ViBandz in the home setting, suggestions for changes/improvements to the ViBandz, and any additional comments. This will be gathered through the use of the System Usability Survey that will be administered via REDCap to parents following use of the ViBandz device for targeted vibration therapy.
Time frame: 3-6 months
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for Mar 2027, 11 months after the start.
Of 52 non-industry observational studies under Neurologic Manifestations, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 339. This study's planned 11 months is below that.
Counting every sponsor, half of 59 studies reached it within 39 months; a quarter within 22 and three quarters within 339.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Oct 2026 → Mar 2027 and completion Dec 2026 → Mar 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Mercy Hospital Kansas City →